ID   LN-427
AC   CVCL_6841
SY   LN 427; LN427
DR   cancercelllines; CVCL_6841
DR   Cosmic; 849869
DR   Wikidata; Q54902782
RX   PubMed=10416987;
RX   PubMed=22570425;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys176Ser (c.526T>A); ClinVar=VCV000376570; Zygosity=Unspecified (PubMed=10416987).
CC   Derived from site: In situ; Brain, left temporo-parietal junction; UBERON=UBERON_0023852.
ST   Source(s): PubMed=22570425
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 11,12
ST   D18S51: 12,15
ST   D21S11: 28
ST   D3S1358: 15,16
ST   D5S818: 10,12
ST   D7S820: 8,9
ST   D8S1179: 11,13
ST   FGA: 23,24
ST   Penta D: 8,9
ST   Penta E: 11
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 18
//
RX   PubMed=10416987; DOI=10.1111/j.1750-3639.1999.tb00536.x; PMCID=PMC8098486;
RA   Ishii N., Maier D., Merlo A., Tada M., Sawamura Y., Diserens A.-C.,
RA   Van Meir E.G.;
RT   "Frequent co-alterations of TP53, p16/CDKN2A, p14ARF, PTEN tumor
RT   suppressor genes in human glioma cell lines.";
RL   Brain Pathol. 9:469-479(1999).
//
RX   PubMed=22570425; DOI=10.1093/neuonc/nos072; PMCID=PMC3367844;
RA   Bady P., Diserens A.-C., Castella V., Kalt S., Heinimann K.,
RA   Hamou M.-F., Delorenzi M., Hegi M.E.;
RT   "DNA fingerprinting of glioma cell lines and considerations on
RT   similarity measurements.";
RL   Neuro-oncol. 14:701-711(2012).
//